Skip to search formSkip to main contentSkip to account menu

AE0047

Known as: AE 0047, AE-0047 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
1. The present study was designed to investigate the anti‐atherosclerotic effect of AE0047, a calcium channel blocker, and to… 
1997
1997
Chronic hypertension is associated with structural and functional changes in the cerebrovascular bed, which influence cerebral… 
1997
1997
1. The present study was designed to investigate the preventative and therapeutic effects of AE0047 on renal injury compared with… 
1997
1997
1. AE0047 is a new dihydropyridine calcium antagonist with protective effects against cerebral ischaemia and the occurrence of… 
1997
1997
The hypotension induced by peripheral vasodilators is occasionally accompanied by diminished urine formation induced via various… 
1997
1997
The antihypertensive effects of oral or intravenous administration of AE0047, a novel 1,4-dihydropyridine-type calcium antagonist… 
1997
1997
The antihypertensive effects of AE0047, a novel 1,4-dihydropyridine-type calcium antagonist, were investigated in spontaneously… 
1995
1995
The effect of AE0047 on contractile responses to high K+ and agonists and to perivascular nerve stimulation was investigated… 
1992
1992
We examined the cerebral protective effects of AE0047 employing cerebral ischemia models. In the bilateral carotid arterial… 
1990
1990
AE0047, a novel calcium antagonist, has mild and long-acting hypotensive effects. This drug also has more selective dilating…